Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
SEC Accession No. 0002100119-26-000207
Filing Date
2026-04-29
Accepted
2026-04-29 17:00:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5657
  Complete submission text file 0002100119-26-000207.txt   7461
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E SUITE 1500 MINNEAPOLIS MN 55413 612-379-8854
BIO-TECHNE Corp (Subject) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-42508 | Film No.: 26917608
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 VANGUARD BLVD MALVERN PA 19355
Business Address 100 VANGUARD BLVD MALVERN PA 19355 610-669-6148
VANGUARD CAPITAL MANAGEMENT LLC (Filed by) CIK: 0002100119 (see all company filings)

EIN.: 392877419 | State of Incorp.: PA | Fiscal Year End: 1231
LEI: 529900ZEWTRLEJ6XE960
Type: SCHEDULE 13G